Ni Catherine, Chiu Melvin W
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, CA, USA.
Clin Cosmet Investig Dermatol. 2014 Apr 17;7:119-32. doi: 10.2147/CCID.S44843. eCollection 2014.
Psoriasis is a chronic inflammatory skin disease affecting approximately 2% of the population worldwide. In the past decade, many studies have drawn attention to comorbid conditions in psoriasis. This literature review examines the epidemiological evidence, pathophysiological commonalities, and therapeutic implications for different comorbidities of psoriasis. Cardiovascular disease, obesity, diabetes, hypertension, dyslipidemia, metabolic syndrome, nonalcoholic fatty liver disease, cancer, anxiety and depression, and inflammatory bowel disease have been found at a higher prevalence in psoriasis patients compared to the general population. Because of the wide range of comorbid conditions associated with psoriasis, comprehensive screening and treatment must be implemented to most effectively manage psoriasis patients.
银屑病是一种慢性炎症性皮肤病,全球约2%的人口受其影响。在过去十年中,许多研究已关注到银屑病的合并症。这篇文献综述探讨了银屑病不同合并症的流行病学证据、病理生理共性及治疗意义。与普通人群相比,银屑病患者中心血管疾病、肥胖症、糖尿病、高血压、血脂异常、代谢综合征、非酒精性脂肪性肝病、癌症、焦虑和抑郁以及炎症性肠病的患病率更高。由于银屑病相关合并症范围广泛,必须实施全面筛查和治疗,以最有效地管理银屑病患者。